JingHai Chen Laboratory
JingHai Chen
Researcher, Doctoral Supervisor
Research Interests:
Cardiometabolism and homeostasis
JingHai Chen

Introduction

Jinghai Chen - Personal Profile

     

JinghaiChen PhD

Principal Investigator

Institute of Translational Medicine of Zhejiang University

The Second Affiliated Hospital of Zhejiang University

     

Education 

09/2001-12/2006  PhD

 Peking Union Medical College & Chinese Academy of Medical Science

09/1997-07/2001  BS

 Zhejiang University

     

Academic Appointments

 2015/03- 

 Principal Investigator

 Institute of Translational Medicine, the Second Affiliated Hospital,Zhejiang University

 2011/12~015/03

 Instructor

 Boston Children’s Hospital, Harvard Medical School

 2010/02~2011/12

 Postdoctoral Fellow

 Boston Children’s Hospital, Harvard Medical School

 2007/03~2010/02

 Postdoctoral Fellow

 Sanford Research, University of South Dakota

     

Research area

Cardiovascular diseases are the main cause of death worldwide. The adult heart is primarily composed of terminally differentiated cardiomyocytes that exit the cell cycle. Under disease stress, cardiomyocytes die and the survival cardiomyocytes compensatorilyturn into hypertrophic remodeling. Then heart gets decompensation, eventually leading to heart failure. The molecular mechanism that controls cardiac remodeling and regeneration during diseases are not fully understood. My researches have been focused on cardiovascular diseases from development, adult heart remodeling and cardiac regeneration. Especially, I would like, but not limited, to elucidate how noncoding RNA regulatescardiac hypertrophy and cardiac regeneration during the cardiovascular diseases.We use cardiac cell system, mouse genetic model and AAV system to study the cardiovascular diseases. We apply a variety of molecular, cellular, and genetic approaches.

Institute of Translational Medicine, Zhejiang University
Address: 268 Kaixuan Road, Shangcheng District, Hangzhou City, Zhejiang Province
Tel: 0571-86971812 / 0571-88981576

Wechat Public